{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:39:30Z","timestamp":1792715970382,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI148684"],"award-info":[{"award-number":["UM1AI148684"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI148576"],"award-info":[{"award-number":["UM1AI148576"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77936-9","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:03:07Z","timestamp":1790121787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic and Mucosal Antibody Responses Against Neisseria gonorrhoeae (Ng) Outer Membrane Vesicle Antigens following Four-Component Meningococcal Serogroup B (4CMenB) Immunization in Healthy Adults: A Randomized Phase II Trial"],"prefix":"10.1038","volume":"17","author":[{"given":"Varun K.","family":"Phadke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Sannigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-1932","authenticated-orcid":false,"given":"Erin M.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen F.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maranda","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori M.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Orndahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ross","family":"Colgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-7919","authenticated-orcid":false,"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ling","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-660X","authenticated-orcid":false,"given":"David S.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"77936_CR1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021). World Health Organization (2021)."},{"key":"77936_CR2","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","volume":"2","author":"M Unemo","year":"2021","unstructured":"Unemo, M. et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe 2, e627\u2013e636 (2021).","journal-title":"Lancet Microbe"},{"key":"77936_CR3","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2020.02.073","volume":"38","author":"SL Gottlieb","year":"2020","unstructured":"Gottlieb, S. L. et al. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 38, 4362\u20134373 (2020).","journal-title":"Vaccine"},{"key":"77936_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S1473-3099(21)00744-1","volume":"22","author":"LK Whittles","year":"2022","unstructured":"Whittles, L. K., Didelot, X. & White, P. J. Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis. Lancet Infect. Dis. 22, 1030\u20131041 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/infdis\/jiae123","volume":"231","author":"D Nikitin","year":"2025","unstructured":"Nikitin, D., Whittles, L. K., Imai-Eaton, J. W. & White, P. J. Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection. J. Infect. Dis. 231, 71\u201383 (2025).","journal-title":"J. Infect. Dis."},{"key":"77936_CR6","first-page":"53","volume":"18","author":"O P\u00e9rez","year":"2009","unstructured":"P\u00e9rez, O. et al. Mucosal approaches in Neisseria vaccinology. VacciMonitor 18, 53\u201355 (2009).","journal-title":"VacciMonitor"},{"key":"77936_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3201\/eid2206.151093","volume":"22","author":"J Whelan","year":"2016","unstructured":"Whelan, J., Klovstad, H., Haugen, I. L., Holle, M. R. & Storsaeter, J. Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway. Emerg. Infect. Dis. 22, 1137\u20131139 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"77936_CR8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","volume":"390","author":"H Petousis-Harris","year":"2017","unstructured":"Petousis-Harris, H. et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 390, 1603\u20131610 (2017).","journal-title":"Lancet"},{"key":"77936_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00094-23","volume":"37","author":"E Williams","year":"2024","unstructured":"Williams, E. et al. Neisseria gonorrhoeae vaccines: a contemporary overview. Clin. Microbiol Rev. 37, e0009423 (2024).","journal-title":"Clin. Microbiol Rev."},{"key":"77936_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/QCO.0000000000000992","volume":"37","author":"A Waltmann","year":"2024","unstructured":"Waltmann, A., Chen, J. S. & Duncan, J. A. Promising developments in gonococcal vaccines. Curr. Opin. Infect. Dis. 37, 63\u201369 (2024).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"77936_CR11","unstructured":"GSK Vaccines. Bexsero Prescribing Information. (2015)."},{"key":"77936_CR12","doi-asserted-by":"crossref","unstructured":"Longtin, J. et al. Possible impact of wide-scale vaccination against serogroup b neisseria meningitidis on gonorrhea incidence rates in one region of Quebec, Canada. In: IDWeek 2017.) (2017).","DOI":"10.1093\/ofid\/ofx180.002"},{"key":"77936_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","volume":"22","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. Lancet Infect. Dis. 22, 1011\u20131020 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","volume":"22","author":"WE Abara","year":"2022","unstructured":"Abara, W. E. et al. Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study. Lancet Infect. Dis. 22, 1021\u20131029 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jinf.2023.05.021","volume":"87","author":"B Wang","year":"2023","unstructured":"Wang, B. et al. 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation. J. Infect. 87, 95\u2013102 (2023).","journal-title":"J. Infect."},{"key":"77936_CR16","doi-asserted-by":"publisher","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","volume":"76","author":"KJ Bruxvoort","year":"2023","unstructured":"Bruxvoort, K. J. et al. Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California. Clin. Infect. Dis. 76, e1341\u2013e1349 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"77936_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/OLQ.0000000000001771","volume":"50","author":"AR Raccagni","year":"2023","unstructured":"Raccagni, A. R. et al. Meningococcus B vaccination effectiveness against neisseria gonorrhoeae infection in people living with HIV: a case-control study. Sex. Transm. Dis. 50, 247\u2013251 (2023).","journal-title":"Sex. Transm. Dis."},{"key":"77936_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae726","volume":"12","author":"B Wang","year":"2025","unstructured":"Wang, B. et al. Long-term 4CMenB Vaccine Effectiveness Against Gonococcal Infection at Four Years Post-Program Implementation: Observational Case-Control Study. Open Forum Infect. Dis. 12, ofae726 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"77936_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae562","volume":"11","author":"AR Raccagni","year":"2024","unstructured":"Raccagni, A. R. et al. Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features. Open Forum Infect. Dis. 11, ofae562 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"77936_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","volume":"24","author":"JM Molina","year":"2024","unstructured":"Molina, J. M. et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 x 2 factorial design. Lancet Infect. Dis. 24, 1093\u20131104 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR21","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S1473-3099(24)00452-3","volume":"24","author":"PJ White","year":"2024","unstructured":"White, P. J., Leng, T., Nikitin, D. & Whittles, L. K. The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial. Lancet Infect. Dis. 24, e543 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJMoa2516739","volume":"395","author":"KL Seib","year":"2026","unstructured":"Seib, K. L. et al. Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection. N. Engl. J. Med 395, 349\u2013361 (2026).","journal-title":"N. Engl. J. Med"},{"key":"77936_CR23","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1016\/S1473-3099(24)00031-8","volume":"24","author":"SN Ladhani","year":"2024","unstructured":"Ladhani, S. N. et al. Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK. Lancet Infect. Dis. 24, e576\u2013e583 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR24","unstructured":"Direcci\u00f3n Xeral De Sa\u00fade P\u00fablica. Vacinaci\u00f3n Para a Prevenci\u00f3n Dunha Infecci\u00f3n de Transmisi\u00f3n Sexual: Gonorrea.) (2025)."},{"key":"77936_CR25","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/OLQ.0000000000001793","volume":"50","author":"WE Abara","year":"2023","unstructured":"Abara, W. E. et al. Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea. Sex. Transm. Dis. 50, e8\u2013e10 (2023).","journal-title":"Sex. Transm. Dis."},{"key":"77936_CR26","doi-asserted-by":"publisher","first-page":"e2331742","DOI":"10.1001\/jamanetworkopen.2023.31742","volume":"6","author":"SG Robison","year":"2023","unstructured":"Robison, S. G. & Leman, R. F. Association of group B meningococcal vaccine receipt with reduced gonorrhea incidence among university students. JAMA Netw. Open 6, e2331742 (2023).","journal-title":"JAMA Netw. Open"},{"key":"77936_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","volume":"69","author":"EA Semchenko","year":"2019","unstructured":"Semchenko, E. A., Tan, A., Borrow, R. & Seib, K. L. The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae. Clin. Infect. Dis. 69, 1101\u20131111 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"77936_CR28","doi-asserted-by":"publisher","first-page":"e01668","DOI":"10.1128\/mBio.01668-19","volume":"10","author":"H Marjuki","year":"2019","unstructured":"Marjuki, H. et al. Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine. mBio 10, e01668\u201319 (2019).","journal-title":"mBio"},{"key":"77936_CR29","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/infdis\/jiy609","volume":"219","author":"PT Beernink","year":"2019","unstructured":"Beernink, P. T. et al. A Meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed factor h binding protein elicits gonococcal bactericidal antibodies. J. Infect. Dis. 219, 1130\u20131137 (2019).","journal-title":"J. Infect. Dis."},{"key":"77936_CR30","doi-asserted-by":"publisher","first-page":"e1008602","DOI":"10.1371\/journal.ppat.1008602","volume":"16","author":"I Leduc","year":"2020","unstructured":"Leduc, I. et al. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae. PLoS Pathog. 16, e1008602 (2020).","journal-title":"PLoS Pathog."},{"key":"77936_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/infdis\/jiab450","volume":"225","author":"KA Matthias","year":"2022","unstructured":"Matthias, K. A. et al. Meningococcal detoxified outer membrane vesicle vaccines enhance gonococcal clearance in a murine infection model. J. Infect. Dis. 225, 650\u2013660 (2022).","journal-title":"J. Infect. Dis."},{"key":"77936_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00309-23","volume":"91","author":"MC Gray","year":"2023","unstructured":"Gray, M. C. et al. Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine. Infect. Immun. 91, e0030923 (2023).","journal-title":"Infect. Immun."},{"key":"77936_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51053-x","volume":"15","author":"L Stejskal","year":"2024","unstructured":"Stejskal, L. et al. Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population. Nat. Commun. 15, 6712 (2024).","journal-title":"Nat. Commun."},{"key":"77936_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1350344","volume":"15","author":"YL Tzeng","year":"2024","unstructured":"Tzeng, Y. L., Sannigrahi, S., Borrow, R. & Stephens, D. S. Neisseria gonorrhoeae lipooligosaccharide glycan epitopes recognized by bactericidal IgG antibodies elicited by the meningococcal group B-directed vaccine, MenB-4C. Front Immunol. 15, 1350344 (2024).","journal-title":"Front Immunol."},{"key":"77936_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01018-4","volume":"9","author":"YL Tzeng","year":"2024","unstructured":"Tzeng, Y. L., Sannigrahi, S. & Stephens, D. S. NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae. NPJ Vaccines 9, 223 (2024).","journal-title":"NPJ Vaccines"},{"key":"77936_CR36","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/infdis\/jiab211","volume":"224","author":"KL Connolly","year":"2021","unstructured":"Connolly, K. L. et al. Preclinical testing of vaccines and therapeutics for gonorrhea in female mouse models of lower and upper reproductive tract infection. J. Infect. Dis. 224, S152\u2013S160 (2021).","journal-title":"J. Infect. Dis."},{"key":"77936_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJM196810242791701","volume":"279","author":"PL Ogra","year":"1968","unstructured":"Ogra, P. L., Karzon, D. T., Righthand, F. & MacGillivray, M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med 279, 893\u2013900 (1968).","journal-title":"N. Engl. J. Med"},{"key":"77936_CR38","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1128\/IAI.66.12.5889-5896.1998","volume":"66","author":"K Eriksson","year":"1998","unstructured":"Eriksson, K. et al. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect. Immun. 66, 5889\u20135896 (1998).","journal-title":"Infect. Immun."},{"key":"77936_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/515286","volume":"177","author":"WS Gallichan","year":"1998","unstructured":"Gallichan, W. S. & Rosenthal, K. L. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 177, 1155\u20131161 (1998).","journal-title":"J. Infect. Dis."},{"key":"77936_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","volume":"24","author":"KM Pollock","year":"2024","unstructured":"Pollock, K. M. et al. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial. Lancet Infect. Dis. 24, 829\u2013844 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR41","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1099\/vir.0.041061-0","volume":"93","author":"GB Yang","year":"2012","unstructured":"Yang, G. B. et al. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques. J. Gen. Virol. 93, 1506\u20131518 (2012).","journal-title":"J. Gen. Virol."},{"key":"77936_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/vaccines8020219","volume":"8","author":"EA Semchenko","year":"2020","unstructured":"Semchenko, E. A., Day, C. J. & Seib, K. L. The Neisseria gonorrhoeae Vaccine Candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells. Vaccines (Basel) 8, 219 (2020).","journal-title":"Vaccines (Basel)"},{"key":"77936_CR43","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1073\/pnas.1012861108","volume":"108","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. USA 108, 4388\u20134393 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77936_CR44","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","volume":"9","author":"A Lovett","year":"2018","unstructured":"Lovett, A. & Duncan, J. A. Human immune responses and the natural history of neisseria gonorrhoeae infection. Front Immunol. 9, 3187 (2018).","journal-title":"Front Immunol."},{"key":"77936_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","volume":"71","author":"PA Rice","year":"2017","unstructured":"Rice, P. A., Shafer, W. M., Ram, S. & Jerse, A. E. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development. Annu Rev. Microbiol 71, 665\u2013686 (2017).","journal-title":"Annu Rev. Microbiol"},{"key":"77936_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106225","volume":"89","author":"B Wang","year":"2024","unstructured":"Wang, B., Mohammed, H., Andraweera, P., McMillan, M. & Marshall, H. Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. J. Infect. 89, 106225 (2024).","journal-title":"J. Infect."},{"key":"77936_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/infdis\/jiv024","volume":"212","author":"S Gulati","year":"2015","unstructured":"Gulati, S. et al. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model. J. Infect. Dis. 212, 311\u2013315 (2015).","journal-title":"J. Infect. Dis."},{"key":"77936_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03367-23","volume":"17","author":"SA McKeand","year":"2026","unstructured":"McKeand, S. A. et al. Inhibition of Neisseria gonorrhoeae complement-mediated killing during acute gonorrhea is dependent upon the IgG2:IgG3 antibody ratio. mBio 17, e0336723 (2026).","journal-title":"mBio"},{"key":"77936_CR49","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.15585\/mmwr.mm7349a3","volume":"73","author":"S Schillie","year":"2024","unstructured":"Schillie, S. et al. New dosing interval and schedule for the bexsero menb-4c vaccine: updated recommendations of the advisory committee on immunization practices - United States, October 2024. MMWR Morb. Mortal. Wkly Rep. 73, 1124\u20131128 (2024).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"77936_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00305-8","volume":"6","author":"KE Seaton","year":"2021","unstructured":"Seaton, K. E. et al. Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. NPJ Vaccines 6, 56 (2021).","journal-title":"NPJ Vaccines"},{"key":"77936_CR51","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S1473-3099(22)00343-7","volume":"22","author":"PJ White","year":"2022","unstructured":"White, P. J., Nikitin, D. & Whittles, L. K. We need estimates of gonorrhoea vaccine protection and symptomaticity by sex and anatomical site. Lancet Infect. Dis. 22, 937 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"77936_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00042560-200008010-00001","volume":"24","author":"PA Kozlowski","year":"2000","unstructured":"Kozlowski, P. A. et al. Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J. Acquir Immune Defic. Syndr. 24, 297\u2013309 (2000).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"77936_CR53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/130.6.619","volume":"130","author":"MA Apicella","year":"1974","unstructured":"Apicella, M. A. Antigenically distinct populations of Neisseria gonorrhoeae: isolation and characterization of the responsible determinants. J. Infect. Dis. 130, 619\u2013625 (1974).","journal-title":"J. Infect. Dis."},{"key":"77936_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/mmi.14153","volume":"111","author":"YL Tzeng","year":"2019","unstructured":"Tzeng, Y. L. et al. Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging Neisseria meningitidis lineage 11.2 urethritis clade: mutations in the pilMNOPQ operon. Mol. Microbiol 111, 254\u2013268 (2019).","journal-title":"Mol. Microbiol"},{"key":"77936_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 3, 124 (2018).","journal-title":"Wellcome Open Res"},{"key":"77936_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med 26, 1033\u20131036 (2020).","journal-title":"Nat. Med"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77936-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:03:27Z","timestamp":1792713807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77936-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77936"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77936-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"11043"}}